Back to Agenda
Session 9 Track 1: Navigating Medical Communication: Best Practices for Pharma MI
Session Chair(s)
Barbara Nardi, PHARMD
Director of Operations Medical Communications, Thermo Fisher Scientific, Brazil
In this session, we will delve into the complexities of medical communication regulatory compliance within the pharmaceutical industry. Participants will gain a comprehensive understanding of different regulatory frameworks and its implications for medical information (MI) practices. We will discuss common challenges faced by pharma companies and present best practices for ensuring compliance while maintaining effective and transparent communication.
Learning Objective : - Describe the various regulatory frameworks governing medical communication and their implications for MI practices
- Discuss the common challenges faced by pharma companies in adhering to regulatory requirements and explore strategies to overcome
- Explain how to implement best practices for ensuring regulatory compliance while maintaining effective and transparent communication
Speaker(s)
Natalia Sanchez Gandarillas, MPHARM, RPH
Associate Director Med Affairs and Med Info, EVERSANA, United Kingdom
From Compliance to Confidence: Interupting EU Regulations to Strengthen MI Strategy
Isabel Bretas, PHARMD
Medical Services Associate Director, PTC Therapeutics, Brazil
Medical Communications Considerations Across the Americas
Have an account?